This inventor holds 3 USPTO granted patents. Top assignees: Baylor College of Medicine, The University of Texas System, William Marsh Rice University. Active years: 2012-2019.
Company Filing History:
2 out of 617 
2 out of 5,633 
1 out of 661 
Years Active: 2012-2019
Title: Pietro Morlacchi: Innovator in STAT6 Inhibitors
Introduction
Pietro Morlacchi is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit the STAT6 pathway. With a total of 3 patents to his name, Morlacchi's work is paving the way for new treatments for various diseases.
Latest Patents
Morlacchi's latest patents focus on STAT6 inhibitors. The present disclosure provides compounds that are useful for inhibiting the STAT6 pathway. Additionally, it includes related pharmaceutical compositions and methods of using these compounds. In some embodiments, the compounds may be used to treat diseases such as allergic lung disease, allergic rhinitis, chronic pulmonary obstructive disease, or cancer.
Career Highlights
Throughout his career, Morlacchi has worked with prestigious institutions, including the University of Texas System and Baylor College of Medicine. His research has been instrumental in advancing the understanding and treatment of diseases related to the STAT6 pathway.
Collaborations
Morlacchi has collaborated with esteemed colleagues such as John S McMurray and Pijus K Mandal. These partnerships have further enriched his research and contributed to the success of his innovations.
Conclusion
Pietro Morlacchi is a prominent inventor whose work on STAT6 inhibitors is making a significant impact in the pharmaceutical industry. His contributions are essential for developing new therapeutic options for patients suffering from various diseases.